Abstract

Pharmacological and initial therapeutic observations on 6-Diazo-5-Oxo-L-Norleucine (Don) in human neoplastic disease

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Clinical studies on triethylenephosphoramide and diethylenephosphoramide, compounds with nitrogen-mustard-like activity
Marguerite P Sykes ... Joseph H Burchenal
Cancer | VOL. 6
Marguerite P Sykes, et. al.Marguerite P Sykes ... Joseph H Burchenal
01 Jan 1953
Effects of continuous hepatic artery infusion of antimetabolites on primary and metastatic cancer of the liver.
Arnold Berrett ... Matthew Kim
Cancer | VOL. 15
Arnold Berrett, et. al.Arnold Berrett ... Matthew Kim
01 May 1962
The use of hydrocortisone in cancer.
C D West ... M C Li
Annals of the New York Academy of Sciences | VOL. 61
C D West, et. al.C D West ... M C Li
01 May 1955
SERUM 5'-NUCLEOTIDASE IN PATIENTS WITH CANCER.
Morton K Schwartz ... Oscar Bodansky
Cancer | VOL. 18
Morton K Schwartz, et. al.Morton K Schwartz ... Oscar Bodansky
01 Jul 1965
View more papers

More From: Cancer

Paper Title
Journal
Date
Author
FDA approves first immunotherapy drug for nasopharyngeal carcinoma.
Mary Beth Nierengarten
Cancer | VOL. 130
Mary Beth NierengartenMary Beth Nierengarten
01 Jun 2024
Rethinking dose optimization in drug development: A goal of Project Optimus is to educate and collaborate with drug developers to select doses of drugs under investigation with a focus on maximizing efficacy, safety, and tolerability.
Mary Beth Nierengarten
Cancer | VOL. 130
Mary Beth NierengartenMary Beth Nierengarten
01 Jun 2024
Cancer Statistics 2024: Deaths drop, incidences increase, prevention needed.
Mary Beth Nierengarten
Cancer | VOL. 130
Mary Beth NierengartenMary Beth Nierengarten
01 Jun 2024
-
-
Cancer | VOL. -
--
01 Jun 2024
View more papers